prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: Right Breast Cancer. POSTOPERATIVE DIAGNOSIS: OPERATION: Lumpectomy Right Breast, Right Sentinel Lymph Node Biopsy. SPECIMEN: A) Right Breast Mass - 1 Short Anterior - 2 Short Superior - 1 Long. Medial, B) Sentinel Node #1 F.S., C) Sentinel Node #2 F.S., D) Axillary Contents E). Gross Margin Additional Inferior Margin Right Breast Mass suture New Inferior Margin. FROZEN SECTION DIAGNOSIS: A) GROSS MARGINS: VERY CLOSE (LESS THAN 1 MM), TO. INFERIOR MARGIN. B) SENT LYMPH NODE #1 - POSITIVE FOR METASTATIC. CARCINOMA. C) SENT LYMPH NODE #2 - POSITIVE FOR METASTATIC. CARCINOMA. Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: FINAL DIAGNOSIS: A) RIGHT BREAST TISSUE - POORLY DIFFERENTIATED. INFILTRATING DUCTAL CARCINOMA. SCARFF-BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 3.5 CM. IN MAXIMUM DIMENSION AND. FOCALLY CLOSE TO ANTERIOR AND POSTERIOR SURGICAL. MARGINS, (LESS THAN 1 MM.), SLIDES #5 AND #6. THE REMAINING SURGICAL MARGINS ARE FREE OF THE. LESION. LYMPHOVASCULAR INVASION IS IDENTIFIED. MICROCALCIFICATIONS ARE IDENTIFIED. B) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). C) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). D) AXILLARY CONTENTS - 2 OF 13 LYMPH NODES ARE POSITIVE FOR. MALIGNANCY, (2/13). E) ADDITIONAL RIGHT BREAST TISSUE - NEGATIVE FOR. MALIGNANCY. PTNM CLASSIFICATION: PIIIa, T2, N2, MX.

expanded version (tokens=922) : 
 The breast pathology report reveals the following information:

1. Histological classification: The patient is diagnosed with infiltrating ductal carcinoma, which is a poorly differentiated type of breast cancer.

2. Subtype: The subtype of breast cancer is LumB.

3. Necrosis: The report does not provide any information about necrosis.

4. Tumor infiltrating lymphocytes: The report does not mention anything about tumor infiltrating lymphocytes.

5. Histological grade: The Scarff-Bloom-Richardson (SBR) grading system is used to classify the histological grade of the tumor as grade III/III, indicating a high degree of malignancy.

6. Nuclear grade: The report does not provide any information about the nuclear grade.

7. Lymphovascular invasion: The report identifies the presence of lymphovascular invasion.

8. Calcification: The report identifies the presence of microcalcifications.

9. Receptor status: The report does not provide any information about the receptor status.

10. IHC and ancillary testing: The report does not mention any specific results of immunohistochemistry (IHC) or ancillary testing.

11. Other findings: The report reveals that the patient underwent a lumpectomy of the right breast along with a right sentinel lymph node biopsy. The gross margins were very close to the inferior margin, and the sentinel lymph node #1 and #2 were both positive for metastatic carcinoma. The patient was diagnosed with stage PIII

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1079) : 
 The patient was diagnosed with invasive ductal carcinoma subtype LumB, Scarff-Bloom Richardson grade III/III, with lymphovascular invasion and microcalcifications. Two of thirteen axillary lymph nodes tested positive for malignancy. The gross margins were close to the inferior margin with a small focus remaining less than 1mm. The patient underwent lumpectomy and right sentinel lymph node biopsy resulting in a diagnosis of PTNM classification: PIIIa, TNM staging T2, N2, MX. Updated receptor status requires further testing.

